Inhibition of 15-PGDH Protects Mice from Immune-mediated Bone Marrow Failure

Aplastic anemia (AA) is a human immune mediated bone-marrow failure syndrome that is treated by stem cell transplantation for patients who have a matched related donor or immunosuppressive therapy (IST) for those who do not. Responses to IST are variable, with patients still at risk for prolonged neutropenia, transfusion-dependence, immune suppression, and severe opportunistic infections. Therefore, additional therapies to accelerate hematologic recovery in patients receiving front line IST are needed. We have shown that inhibiting 15-hydroxyprostaglandin dehydrogenase (15-PGDH) with the small molecule SW033291 (PGDHi) increases bone marrow (BM) prostaglandin E2 levels, expands hematopoietic stem cell (HSC) numbers, and accelerates hematologic reconstitution following murine BM transplantation. We now report that in a murine model of immune-mediated BM failure, PGDHi therapy mitigated cytopenias, increased BM HSC and progenitor cells, and significantly extended survival compared to vehicle-treated mice. PGDHi protection was not immune-mediated, as serum IFNγ levels and BM CD8+ T lymphocyte frequencies were not impacted. Moreover, dual administration of PGDHi plus low dose IST enhanced total white blood cell, neutrophil and platelet recovery, achieving responses similar to maximal dose IST at lesser toxicity. Together these data demonstrate that PGDHi can complement IST to accelerate hematologic recovery and reduce morbidity in severe AA.

[1]  Xingmin Feng,et al.  Macrophage TNF-α licenses donor T cells in murine bone marrow failure and can be implicated in human aplastic anemia. , 2018, Blood.

[2]  M. Chapellier,et al.  Interleukin 4 Induces Macrophage-Mediated Phagocytosis of Leukemia Cells , 2018, Blood.

[3]  P. Scheinberg.  Activity of eltrombopag in severe aplastic anemia. , 2018, Blood advances.

[4]  Neal S Young,et al.  Aplastic Anemia , 2018, The New England journal of medicine.

[5]  Angelica Costello,et al.  Hematopoietic stem cell loss and hematopoietic failure in severe aplastic anemia is driven by macrophages and aberrant podoplanin expression , 2018, Haematologica.

[6]  L. Kasturi,et al.  A second-generation 15-PGDH inhibitor promotes bone marrow transplant recovery independently of age, transplant dose and granulocyte colony-stimulating factor support , 2018, Haematologica.

[7]  A. Bacigalupo.  How I treat acquired aplastic anemia. , 2017, Blood.

[8]  J. Smith,et al.  Hematopoietic Stem Cell Regulation by Type I and II Interferons in the Pathogenesis of Acquired Aplastic Anemia , 2016, Front. Immunol..

[9]  Xingmin Feng,et al.  IFN-γ-mediated hematopoietic cell destruction in murine models of immune-mediated bone marrow failure. , 2015, Blood.

[10]  S. Miyano,et al.  Somatic Mutations and Clonal Hematopoiesis in Aplastic Anemia. , 2015, The New England journal of medicine.

[11]  K. Bae,et al.  Inhibition of the prostaglandin-degrading enzyme 15-PGDH potentiates tissue regeneration , 2015, Science.

[12]  Xingmin Feng,et al.  Immune-mediated bone marrow failure in C57BL/6 mice. , 2015, Experimental hematology.

[13]  P. Plett,et al.  Recovery from hematopoietic injury by modulating prostaglandin E(2) signaling post-irradiation. , 2013, Blood cells, molecules & diseases.

[14]  K. McGrath,et al.  Prostaglandin E2 Increases Hematopoietic Stem Cell Survival and Accelerates Hematopoietic Recovery After Radiation Injury , 2013, Stem cells.

[15]  N. Young,et al.  How I treat acquired aplastic anemia. , 2012, Blood.

[16]  N. Young,et al.  Cyclosporine Taper Does Not Prevent Relapse in Severe Aplastic Anemia , 2011 .

[17]  J. Qin,et al.  Irgm1 protects hematopoietic stem cells by negative regulation of IFN signaling. , 2011, Blood.

[18]  Nathan C Boles,et al.  Quiescent hematopoietic stem cells are activated by IFNγ in response to chronic infection , 2010, Nature.

[19]  J. Sampath,et al.  Prostaglandin E2 enhances hematopoietic stem cell homing, survival, and proliferation. , 2009, Blood.

[20]  N. Young,et al.  Aplastic anemia , 2008, Current opinion in hematology.

[21]  Jichun Chen,et al.  Bystander destruction of hematopoietic progenitor and stem cells in a mouse model of infusion-induced bone marrow failure. , 2004, Blood.

[22]  T. Hosoya,et al.  Long‐term administration of G‐CSF for aplastic anaemia is closely related to the early evolution of monosomy 7 MDS in adults , 1998, British journal of haematology.